Terms: = Prostate cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
36 results:
1. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.
Ashrafizadeh M; Zhang W; Tian Y; Sethi G; Zhang X; Qiu A
Cancer Metastasis Rev; 2024 Mar; 43(1):229-260. PubMed ID: 38374496
[TBL] [Abstract] [Full Text] [Related]
2. NCAPG2 promotes prostate cancer malignancy and stemness via stat3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract] [Full Text] [Related]
3. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
4. stat3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.
Hashemi M; Abbaszadeh S; Rashidi M; Amini N; Talebi Anaraki K; Motahhary M; Khalilipouya E; Harif Nashtifani A; Shafiei S; Ramezani Farani M; Nabavi N; Salimimoghadam S; Aref AR; Raesi R; Taheriazam A; Entezari M; Zha W
Environ Res; 2023 Sep; 233():116458. PubMed ID: 37348629
[TBL] [Abstract] [Full Text] [Related]
5. Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/stat3 pathway.
Ji Y; Liu B; Chen L; Li A; Shen K; Su R; Zhang W; Zhu Y; Wang Q; Xue W
Cell Oncol (Dordr); 2023 Oct; 46(5):1445-1456. PubMed ID: 37120492
[TBL] [Abstract] [Full Text] [Related]
6. stat3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Motahhary M; Saghari S; Sharifi L; Bokaie S; Mirzaei S; Entezari M; Aref AR; Salimimoghadam S; Rashidi M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114168. PubMed ID: 36916439
[TBL] [Abstract] [Full Text] [Related]
7. Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance.
Peng G; Wang C; Wang H; Qu M; Dong K; Yu Y; Jiang Y; Gan S; Gao X
Oncoimmunology; 2023; 12(1):2173422. PubMed ID: 36776524
[TBL] [Abstract] [Full Text] [Related]
8. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
9. Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes.
Karpova Y; Johnson SJ; Bordet G; Guo D; Ghatak A; Markov DA; Tulin AV
Biomed Pharmacother; 2022 Sep; 153():113504. PubMed ID: 36076593
[TBL] [Abstract] [Full Text] [Related]
10. ARPC1A is regulated by stat3 to inhibit ferroptosis and promote prostate cancer progression.
Ji J; Li H; Wang W; Yuan B; Shen T
Hum Cell; 2022 Sep; 35(5):1591-1601. PubMed ID: 35871131
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention.
Mirzaei S; Paskeh MDA; Okina E; Gholami MH; Hushmandi K; Hashemi M; Kalu A; Zarrabi A; Nabavi N; Rabiee N; Sharifi E; Karimi-Maleh H; Ashrafizadeh M; Kumar AP; Wang Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):214. PubMed ID: 35773731
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Potential Key Genes in prostate cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.
Khan MM; Mohsen MT; Malik MZ; Bagabir SA; Alkhanani MF; Haque S; Serajuddin M; Bharadwaj M
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456461
[TBL] [Abstract] [Full Text] [Related]
13. stat3, VEGF, and PSMA Expression Patterns in Malignant Peripheral Nerve Sheath Tumors, Malignant Melanomas, and Glioblastomas: Does Staining Percentage and Intensity Have an Effect on Survival?
Coskun SK; Gamsizkan M; Yalcınkaya U; Sungur MA
J Environ Pathol Toxicol Oncol; 2022; 41(1):45-53. PubMed ID: 35378003
[TBL] [Abstract] [Full Text] [Related]
14. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-stat3 signaling in hepatocellular carcinoma.
Wang LL; Luo J; He ZH; Liu YQ; Li HG; Xie D; Cai MY
Cell Death Dis; 2021 Nov; 12(11):1052. PubMed ID: 34741044
[TBL] [Abstract] [Full Text] [Related]
15. PIWI‑interacting RNA in cancer: Molecular mechanisms and possible clinical implications (Review).
Yuan C; Qin H; Ponnusamy M; Chen Y; Lin Z
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34328192
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract] [Full Text] [Related]
17. Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment.
Zhu W; Sheng D; Shao Y; Zhang Q; Peng Y
Peptides; 2021 Jan; 135():170423. PubMed ID: 33086087
[TBL] [Abstract] [Full Text] [Related]
18. Leptin Promotes prostate cancer Proliferation and Migration by Stimulating stat3 Pathway.
Gorrab A; Pagano A; Ayed K; Chebil M; Derouiche A; Kovacic H; Gati A
Nutr Cancer; 2021; 73(7):1217-1227. PubMed ID: 32698628
[TBL] [Abstract] [Full Text] [Related]
19. stat3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Oberhuber M; Pecoraro M; Rusz M; Oberhuber G; Wieselberg M; Haslinger P; Gurnhofer E; Schlederer M; Limberger T; Lagger S; Pencik J; Kodajova P; Högler S; Stockmaier G; Grund-Gröschke S; Aberger F; Bolis M; Theurillat JP; Wiebringhaus R; Weiss T; Haitel A; Brehme M; Wadsak W; Griss J; Mohr T; Hofer A; Jäger A; Pollheimer J; Egger G; Koellensperger G; Mann M; Hantusch B; Kenner L
Mol Syst Biol; 2020 Apr; 16(4):e9247. PubMed ID: 32323921
[TBL] [Abstract] [Full Text] [Related]
20. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/stat3 signaling.
Huang R; Wang S; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Guo L; Wang S; Chen Z; Wang Z; Xiang S
Cell Death Dis; 2020 Apr; 11(4):234. PubMed ID: 32300100
[TBL] [Abstract] [Full Text] [Related]
[Next]
